The Genetic Association of SP-A and SP-D Polymorphisms with Tuberculosis and Latent TB in the Pakistani Population

This case-control study of the Pakistani population found that while SP-A1 (rs1059047) and SP-D (rs3088308) polymorphisms are not significantly associated with overall tuberculosis susceptibility, the SP-D homozygous TT genotype may confer protection against latent TB infection.

The Gist

🛡️ The Big Picture: The Body's "Security Guards" vs. The "Invader"

Imagine your lungs are a high-security castle. The enemy is a tiny, sneaky invader called Tuberculosis (TB).

Inside your castle, you have a specialized security team called Surfactant Proteins A and D (SP-A and SP-D). Think of these proteins as the castle's security guards. Their job is to spot the TB bacteria, grab them, and hand them over to the "trash collectors" (immune cells called macrophages) to be destroyed.

However, just like people, security guards come in different "flavors" or versions. Some are super-efficient, while others are a bit clumsy. These different versions are caused by tiny typos in your DNA, called polymorphisms (or SNPs).

The Question: The researchers wanted to know: In the Pakistani population, do specific "flavors" of these security guards make people more likely to catch TB, or better at fighting it off?

---

🔬 The Experiment: A Three-Group Test

The researchers gathered 350 people from Pakistan and split them into three teams:

1. The Sick Team (100 people): People currently fighting active TB.
2. The "Almost" Team (100 people): People who live with someone who has TB but aren't sick yet. (These are called "contacts" and likely have a "silent" or Latent TB infection).
3. The Healthy Team (150 people): People with no TB history and no contact with sick people.

They took blood samples from everyone and looked at their DNA to see which "flavor" of security guard (SP-A and SP-D) they had.

---

🧪 The Findings: What Did They Discover?

1. The First Guard (SP-A): "No Difference Found"

The researchers looked at the SP-A guard (specifically a typo called rs1059047).

• The Result: It didn't matter which version of this guard a person had. Whether they had the "super" version or the "average" version, it didn't seem to change their chances of getting TB.
• The Analogy: Imagine checking if people wear red or blue shoes. The study found that wearing red or blue shoes had zero effect on whether you got caught by the TB invader. Everyone was equally vulnerable or immune regardless of this specific trait.

2. The Second Guard (SP-D): "The Lucky Charm!"

The researchers looked at the SP-D guard (specifically a typo called rs3088308).

• The Result: This one was interesting! When they compared the "Healthy Team" to the "Almost Team" (people exposed to TB but not sick), they found a pattern.
• The Discovery: People in the "Almost Team" who had the TT version (a specific genetic code) were significantly less likely to get the silent infection (Latent TB).
• The Analogy: Think of the TT version of the SP-D guard as wearing a super-shiny, high-tech helmet.
  • When the TB bacteria tried to sneak into the lungs of people with this "helmet," the guard was so good at spotting them that the bacteria couldn't even hide.
  • The study found that people with this "helmet" were about 80% less likely to catch the silent infection compared to those without it. It's like having a VIP pass that keeps the bad guys out of the castle.

---

📉 Why Does This Matter?

• For Pakistan: This is the first time scientists have looked at these specific genetic "flavors" in Pakistan. It helps us understand why some people get sick and others don't, even when they are exposed to the same germs.
• The "Silent" Threat: The study highlighted that genetics might be the reason some people exposed to TB stay healthy (Latent TB) while others get sick.
• Future Hope: While this study is just the beginning (it's a "preprint," meaning it hasn't been fully peer-reviewed yet), it suggests that if we can figure out how to boost the "TT" version of the SP-D guard, we might be able to create new treatments or vaccines to protect people from TB.

🏁 The Bottom Line

• SP-A: Doesn't seem to be the hero or the villain in this story for Pakistan.
• SP-D: The TT version is a hero. It acts like a super-shield, protecting people from catching the silent, sleeping form of Tuberculosis.

The researchers are essentially saying: "We found a genetic superpower in some Pakistanis that helps them resist TB. Now we need to study it more to see if we can use that knowledge to save lives."

Technical Summary

1. Problem Statement and Background

• Global Context: Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a critical global health burden, with Pakistan ranking 5th among high-prevalence countries. A significant portion of the global population carries Latent TB Infection (LTBI), which can reactivate into active disease if the host immune system is compromised.
• Biological Mechanism: Innate immunity, specifically alveolar macrophages, plays a crucial role in controlling MTB. Surfactant Protein A (SP-A1) and Surfactant Protein D (SP-D) are C-type lectins (collectins) that facilitate the opsonization and phagocytosis of MTB by macrophages.
• Knowledge Gap: While SP-A1 and SP-D genetic variants are known to influence susceptibility to various lung diseases, there is a lack of data regarding their association with TB and LTBI specifically within the Pakistani population.
• Objective: The study aimed to investigate the association between two specific Single Nucleotide Polymorphisms (SNPs)—SP-A1 rs1059047 (+1101 C/T) and SP-D rs3088308 (911 T/A)—and susceptibility to active TB and LTBI in Pakistan.

2. Methodology

• Study Design: A case-control study involving 350 participants recruited from Nishtar Hospital Multan and Raza Laboratory.
• Study Groups:
  • Active TB Patients (n=100): Newly diagnosed, confirmed via GeneXpert or Chest X-ray.
  • TB Contacts (n=100): Asymptomatic household contacts of index cases within the last 6 months (proxy for LTBI).
  • Healthy Controls (n=150): Asymptomatic individuals with no history of TB contact.
  • Exclusion Criteria: Anemia, HIV, pregnancy, or breastfeeding.
• Genotyping Technique:
  • DNA Extraction: Phenol-chloroform method.
  • PCR Method: Tetra ARMS-PCR (Amplification Refractory Mutation System) was used to distinguish genotypes. This method utilizes two sets of primers (outer and inner) to amplify specific alleles.
  • Primers: Designed using Primer 1 software; specific sequences and annealing temperatures (69°C for rs1059047 and 73°C for rs3088308) were optimized via gradient PCR.
  • Visualization: PCR products were separated on 2% agarose gels and visualized using a Gel Doc system.
• Statistical Analysis:
  • Software: GraphPad Prism v.10.
  • Tests: Chi-square test for Hardy-Weinberg Equilibrium (HWE) and genotype frequency comparisons.
  • Models: Co-dominant, dominant, recessive, and additive genetic models were analyzed to calculate Odds Ratios (OR) and 95% Confidence Intervals (CI).

3. Key Results

A. SP-A1 Polymorphism (rs1059047: +1101 C/T)

• Genotype Distribution: The heterozygous CT genotype was the most prevalent in all groups (~91-93%).
• Association with Active TB: No statistically significant association was found between rs1059047 and active TB susceptibility (p > 0.5 across all genetic models).
  • Example: Co-dominant model p-value = 0.57, OR = 0.65.
• Association with TB Contacts: No significant association was found between this SNP and LTBI status (TB contacts vs. healthy controls).
  • Example: Co-dominant model p-value = 0.25.
• Conclusion: The rs1059047 polymorphism does not appear to influence susceptibility to TB or LTBI in this Pakistani cohort.

B. SP-D Polymorphism (rs3088308: 911 T/A)

• Association with Active TB: Similar to SP-A1, no significant association was found between rs3088308 and active TB susceptibility (p = 0.74 in co-dominant model).
• Association with TB Contacts (LTBI): A significant protective association was observed.
  • Finding: The homozygous TT genotype was significantly more frequent in TB contacts (82.35%) compared to healthy controls (73.53%).
  • Statistical Significance:
    • Co-dominant model: p = 0.00, OR = 0.19 (95% CI: 0.08–0.51).
    • Dominant model: p < 0.00, OR = 0.19.
    • Additive model: p < 0.00, OR = 0.16.
  • Interpretation: The TT genotype is associated with a protective effect against developing LTBI (or potentially indicates a higher rate of clearance of infection) in contacts, whereas the A allele (AA/AT genotypes) was less frequent in contacts.

4. Key Contributions

1. Population-Specific Data: Provides the first genetic association data for SP-A1 and SP-D polymorphisms specifically within the Pakistani population, addressing a gap in global genetic epidemiology.
2. Differentiation of Phenotypes: Successfully distinguished between susceptibility to active disease and latent infection, finding that while neither SNP predicts active disease, SP-D rs3088308 is a significant marker for LTBI status.
3. Methodological Application: Demonstrated the efficacy of Tetra ARMS-PCR as a cost-effective method for genotyping these specific SNPs in a resource-limited setting.
4. Protective Marker Identification: Identified the SP-D rs3088308 TT genotype as a potential protective factor against LTBI, suggesting a role for this specific variant in innate immune clearance mechanisms.

5. Significance and Limitations

• Significance:
  • The findings suggest that while SP-A1 rs1059047 may not be a major driver of TB susceptibility in Pakistan, the SP-D rs3088308 polymorphism plays a critical role in the host's ability to control initial MTB infection (preventing progression to LTBI).
  • Understanding these genetic markers could eventually aid in risk stratification for TB contacts, identifying individuals who are genetically more likely to clear the infection versus those at risk of reactivation.
• Limitations:
  • LTBI Definition: LTBI status was defined based on contact history rather than immunological tests like IGRA or QuantiFERON-TB Gold, which could introduce misclassification bias.
  • Sample Size: The study size (n=350) is modest; larger cohorts are needed to confirm the statistical power of the findings.
  • Functional Validation: The study is observational; it does not include functional assays to measure actual SP-D protein levels or binding affinity in individuals with these genotypes.
  • Preprint Status: As a preprint, the data has not yet undergone peer review.

Conclusion

The study concludes that the SP-D rs3088308 TT genotype is significantly associated with protection against Latent TB Infection in the Pakistani population, whereas the SP-A1 rs1059047 polymorphism shows no significant association with either active TB or LTBI. These results highlight the potential of SP-D genetic variation as a biomarker for innate immune resistance to M. tuberculosis in this specific demographic.